Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer
Prasanna Anjaneyulu Yakkala, Samir Ranjan Panda, V.G.M. Naidu, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 3, pp. 260-269
Open Access | Times Cited: 16

Showing 16 citing articles:

Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
Prasanna Anjaneyulu Yakkala, Naveen Reddy Penumallu, Syed Shafi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1456-1456
Open Access | Times Cited: 28
Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo
Arun N. Prakash, Neethu Prasad, Eswara Rao Puppala, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110585-110585
Closed Access | Times Cited: 25
Ambient particulate matter (PM2.5) exposure contributes to neurodegeneration through the microbiome-gut-brain axis: Therapeutic role of melatonin
Samir Ranjan Panda, Vishal Balu Chaudhari, Sahabuddin Ahmed, et al.
Environmental Toxicology and Pharmacology (2023) Vol. 101, pp. 104183-104183
Closed Access | Times Cited: 15
Loganic Acid Alleviates the Olfactory-Brain NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental Models of Parkinson’s Disease
Samir Ranjan Panda, Pallabi Panja, Meenakshi Singh, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
An update on the development on tubulin inhibitors for the treatment of solid tumors
Prasanna Anjaneyulu Yakkala, Shaik O. Rahaman, P.S. Lakshmi Soukya, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 3, pp. 193-220
Closed Access | Times Cited: 4
PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer
Prasanna Anjaneyulu Yakkala, Fatima Naaz, Syed Shafi, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 3, pp. 159-177
Closed Access | Times Cited: 2
Therapeutic Potential of Methotrexate-Loaded Superparamagnetic Iron Oxide Nanoparticles Coated with Poly(lactic-co-glycolic acid) and Polyethylene Glycol against Breast Cancer: Development, Characterization, and Comprehensive In Vitro Investigation
Sankha Bhattacharya, Bhupendra G. Prajapati, Nemat Ali, et al.
ACS Omega (2023) Vol. 8, Iss. 30, pp. 27634-27649
Open Access | Times Cited: 6
Oxindoline Containing Thiazolidine‐4‐one Tethered Triazoles Act as Antimitotic Agents by Targeting Microtubule Dynamics
Syeda Shahjahan, Lakshmi Tulasi Naraharisetti, Alia Begum, et al.
ChemistrySelect (2024) Vol. 9, Iss. 17
Open Access | Times Cited: 1
Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents
Rabiya Samoon, Shashikanta Sau, Arnab Roy, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 9, pp. 3320-3331
Closed Access | Times Cited: 1
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108011-108011
Closed Access | Times Cited: 1
Design and Synthesis of Michael Acceptor‐Based Peptidyl β‐Nitrostyrenes as 3CLpro Inhibitors of SARS‐CoV‐2
Sweta Sharma, Prasanna Anjaneyulu Yakkala, Jyoti Aboti, et al.
ChemistrySelect (2023) Vol. 8, Iss. 24
Closed Access | Times Cited: 3
5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against Leishmania Donovani
Sweta Sharma, Prasanna Anjaneyulu Yakkala, Mirza Beg, et al.
ChemistrySelect (2023) Vol. 8, Iss. 29
Closed Access | Times Cited: 3
Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment
Rajdeep Tyagi, Kanchan Yadav, Nitin Srivastava, et al.
Current Pharmaceutical Design (2023) Vol. 30, Iss. 4, pp. 255-277
Closed Access | Times Cited: 2
Chalcone derivatives containing 1,2,4-triazole and pyridine moiety: design, synthesis, and antiviral activity
Hui Xin, Jiao Tian, Tianyu Deng, et al.
Molecular Diversity (2024)
Closed Access
Some Novel 5-Benzylidenethiazolo[3,2-b]-1,2,4-triazole-6(5H)-one Derivatives in the Battle Against Cancer: Design, Synthesis and Their Biological Activities
Ahmet Avci, Nazlıhan Aztopal, Nesrin Gökhan-Kelekçi, et al.
Journal of Molecular Structure (2024), pp. 141169-141169
Closed Access
Dual-targeting inhibitors involving tubulin for the treatment of cancer
Prasanna Anjaneyulu Yakkala, Ähmed Kamal
Bioorganic Chemistry (2024) Vol. 156, pp. 108116-108116
Closed Access
Page 1

Scroll to top